Yesterday, the Minnesota Department of Health approved adding Alzheimer’s disease as a qualifying condition for medical cannabis, but rejected opioid use disorder, hepatitis C, traumatic brain injury, and insomnia.
Many thanks to Sensible Minnesota and to all the advocates and health professionals who were involved in petitioning to expand the program! Their dedicated work (with an assist from MPP) also resulted in the addition of intractable pain, PTSD, autism, and sleep apnea.
Under state law, Alzheimer’s disease patients will be able to apply for medical cannabis starting next summer.
Additionally, the board voted to recommend that the state add autism to the list of qualifying conditions, but rejected expanding the program to add ADHD, PTSD, bipolar disorder, and ganglioglioma.
Unfortunately, Iowa’s low-THC approach leaves behind thousands of patients who could benefit from medical marijuana.
Check out our full summary of Iowa’ low-THC program here. Five dispensaries across the state will be open to registered patients on December 1. You can also find a wealth of information on medical marijuana here.
Last November, the Minnesota Department of Health approved adding autism spectrum disorders and obstructive sleep apnea as qualifying conditions for the state’s medical cannabis program. Under state law, the additions take effect the following summer.
Starting on July 1, 2018, patients with a doctor’s certification and either of those conditions could begin registering for the program. They can start accessing medical cannabis no sooner than August 1. Our allies at Sensible Minnesota offer one-on-one assistance to patients who need help navigating the process. Learn more here.
Congratulations to Sensible Minnesota and to all the advocates and health professionals who were involved in petitioning to expand the program!
Sensible Minnesota is now working on petitions to expand the program to include opioid use disorder, hepatitis C, Alzheimer’s, traumatic brain injury, and insomnia.
If you are a Minnesota medical professional who might be willing to add your voice to the petition, contact Sensible Minnesota at 952-529-4420 or by email.
Gov. John Bel Edwards has signed HB 579 and HB 627, which expand the qualifying conditions for medical marijuana! These two bills add a variety of new conditions including autism, PTSD, and intractable pain.
This is a great step towards Louisiana having a functional medical marijuana program. Next session, we are hopeful the legislature will allow the vaporization of medical marijuana so that patients can finally have real access to the medicine they need.
Congratulations to Sensible Marijuana Policy for Louisiana and all the activists that showed up to the statehouse and contacted their lawmakers in support of these reforms!
Last year, MPP helped local advocates at Sensible Minnesota with their successful petition to add post-traumatic stress disorder (PTSD) to the state’s medical cannabis program. Patients suffering from this condition were able to enroll in the program last month, and starting August 1 they will be allowed to access medical cannabis.
Every year, the Minnesota Office of Medical Cannabis accepts petitions to add new conditions, and this year was no exception. This year’s petitions were due this week, and MPP and Sensible Minnesota again submitted paperwork — including for nausea, Alzheimer’s, and autism. Thanks to everyone who shared their story with us to help build the case. Before deciding whether to add the condition, a review panel will hold a public hearing.
While Minnesota has a comprehensive medical marijuana program, it remains one of the most limited — and costly — in the country. One of the most significant remaining flaws is that patients are not permitted to consume whole plant (flower) cannabis.
Texas legislators are back in Austin for another round of policy considerations, and Rep. Eddie Lucio III has introduced HB 85, a medical cannabis improvement bill. This proposal would allow some patients to access whole plant cannabis, including those with terminal cancer, multiple sclerosis, autism, or Parkinson’s Disease.
This bill is more restrictive than the bill introduced during the regular session, but it would still be a major step forward for many seriously ill patients. Currently, the Compassionate Use Program only allows those with intractable epilepsy access to low-THC cannabis. Texas cannabis businesses are expected to be operational by the end of the year.
This will be a very politically charged special session, established to address a specific list of issues that Gov. Greg Abbott and other Texas conservatives consider priorities.
The Minnesota medical cannabis program is now accepting petitions to add qualifying conditions. Once again, MPP is teaming up with local advocate group Sensible Minnesota to petition to expand the program.
Post-traumatic stress disorder — which was added as a result of last year’s petition process — qualifies starting on Aug. 1, and the year before we were successful in efforts to add intractable pain. This year we are looking at adding several new conditions. They are: nausea, autism, dementia, Alzheimer’s disease, liver disease, and chronic pain.
If you suffer from one of these conditions, are the guardian of someone who does, or if you are a health care professional who treats one of these conditions, we want to hear from you! Please fill out this form to let us know who you are, what condition is relevant to you, and to share your story. Sensible Minnesota or MPP Foundation will be submitting letters of support along with the petitions.
Both the Georgia House and Senate this year presented bills that would make changes to the state’s low-THC medical marijuana law. The better of the two, House Bill 65, just passed the House by a huge margin of 156-6 in support. The bill is now on its way to the Senate.
House Bill 65 would increase the list of qualifying medical conditions, adding HIV/AIDS, Alzheimer’s disease, autism, autoimmune disease, peripheral neuropathy, and others, and it would offer basic protections for those patients visiting from out-of-state. Unfortunately for many veterans and others, PTSD was removed from the list while in committee earlier this week.
The Senate’s bill, SB 16, has already passed the Senate. Unfortunately, while it would add autism as a qualifying medical condition, it would lower the total amount of THC allowable in medical marijuana products from 5% to 3%, harming the program for all who participate.
After years of advocacy from patients and their loved ones, the Pennsylvania House of Representatives approved compassionate, comprehensive medical cannabis legislation this evening!
SB 3 will now return to the Senate, which approved the bill last May, to consider the House’s amendments. Gov. Tom Wolf has been a strong champion of the issue and will sign the legislation when it arrives at his desk.
SB 3 allows patients with qualifying conditions to use and safely access medical cannabis with their physicians’ recommendations. As amended by the House, it allows up to 25 growers and processors to produce medical cannabis, which would be dispensed by up to 50 dispensaries with up to three locations each.
Qualifying conditions include cancer, HIV/AIDS, multiple sclerosis, seizures, autism, sickle cell anemia, and intractable pain if conventional therapies or opiates don’t work or are contraindicated. More details are available here.
Thank you to everyone who has worked so hard for so long to make this compassionate bill a reality, including the amazing team at Campaign4Compassion, the American Trade Association for Cannabis and Hemp, Gov. Tom Wolf, Sens. Mike Folmer and Daylin Leach and their staff, especially MP Tomei, Reps. Mike Regan, Nick Miccarelli, Russ Diamond, and Joe Petrarca and staffer Sarah Speed, Majority Leader Dave Reed, and MPP’s lobbyist Jim Davis!
Over the weekend, the November 2015 issue of the Delaware Register of Regulations was published, expanding the legal protections of the state’s medical marijuana act to reach more individuals. The published regulations officially added "autism with self-injurious or aggressive behavior" to the list of conditions, giving doctors one more treatment option should they think it would benefit their patients.
The condition was added after a petition to do so was submitted to the Department of Health and Social Services. The department took testimony and conducted its own research on the matter, and it ultimately concluded that the petition had merit and the condition should be added. This is the first condition to be added by the petition process in Delaware.
Thank you to everyone who spoke in support of the petition, as well as those who attended the Medical Marijuana Act Oversight Committee meeting last week to share your experience with the program to date.